On March 19, Yahoo! News reported GPU service provider CoreWeave has dedicated 6,000 of its specialized Nvidia GPU chips to COVID-19 research. The firm’s hardware is being used by Stanford University’s [email protected] initiative, which has been researching coronavirus pharmaceutical therapies since February 27.
CoreWeave’s Contribution to COVID-19 Research
Currently the largest U.S.-based Ethereum miner, CoreWeave also provides cloud processing services to firms that need CGI rendering and machine learning resources. On Thursday, the firm retasked 6,000 of its 45,000 GPU for the [email protected]’s coronavirus research.
Researchers at Stanford University founded [email protected] as a distributed computer research project. The initiative harnesses the processing power of organizations and individuals all over the world to investigate the function of viral proteins. In doing so, scientists hope to gain a greater understanding of how viruses reproduce and affect the immune system.
In late February, the project put its focus on examining COVID-19. The initiative’s leaders hope to provide doctors and researchers with crucial new information about the disease. By supporting [email protected] with its cutting edge GPUs, CoreWeave has doubled the project’s processing capability.
“The idea of ‘should we do this?’ was never really brought up, it kind of just happened,” said CoreWeave CTO Brian Venturo. “We were all enthusiastic that we might be able to help.”
Organizations Use Tech to Fight the Coronavirus Pandemic
CoreWeave isn’t the only organization to harness technology to aid in the fight against the coronavirus pandemic.
Earlier this month, Tulip.tools founder Johan Tanzer asked Tezos blockchain miners to lend their resources to [email protected] Subsequently, 20 Tezos miners offered some of their hashing power to the research initiative.
On Thursday, The Burn-In covered Nvidia’s efforts to aid COVID-19 researchers. The firm is providing those investigating the disease with access to its Parabricks GPU-accelerated genome sequencing tool for free. Qualified individuals and organizations can use the program with no charge for the next 90 days.
Researchers are also using IBM’s computing innovations to find new ways of treating the pandemic. Biophysicists from the University of Tennessee are using the corporation’s SUMMIT supercomputer to identify components in existing pharmaceuticals for use in the creation of new coronavirus drugs. Based in Oak Ridge National Laboratory, SUMMIT is capable of performing 200 quadrillion calculations per second.
A few days after being tasked with its new project, the supercomputer sifted through 8,000 drug components and found 77 compounds potentially capable of preventing COVID-19 from infecting human cells. The university researchers posted their findings to ChemRxiv, and the paper is currently undergoing peer review.
In addition, Facebook, Microsoft, and the Allen Institute for Artificial Intelligence teamed with a host of other organizations to create the COVID-19 Open Research Dataset. The artificial intelligence-enabled information reservoir features over 24,000 articles about the coronavirus pandemic. The consortium compiled the dataset to give researchers easy access to the latest information on the disease.
Hopefully, doctors and scientists will be able to utilize the world’s technological resources to expedite the production of life-saving coronavirus treatments.